Janssen HL - Search Results

1

van der Meer AJ, Sonneveld M, Schouten JN, Janssen HL. van der Meer AJ, et al. Among authors: janssen hl. Ned Tijdschr Geneeskd. 2014;158:A6790. Ned Tijdschr Geneeskd. 2014. PMID: 24594125 Review. Dutch.

2

[Chronic hepatitis-b-virus infections: new options for antiviral therapy].

de Man RA, Honkoop P, Janssen HL, Schalm SW. de Man RA, et al. Among authors: janssen hl. Ned Tijdschr Geneeskd. 1999 Sep 11;143(37):1857-61. Ned Tijdschr Geneeskd. 1999. PMID: 10526598 Review. Dutch.

3

[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].

van der Eijk AA, Doorduijn JK, Janssen HL, Schalm SW, Niesters HG, de Man RA. van der Eijk AA, et al. Among authors: janssen hl. Ned Tijdschr Geneeskd. 2002 Jun 15;146(24):1140-4. Ned Tijdschr Geneeskd. 2002. PMID: 12092307 Dutch.

4

[Fatal fibrosing cholestatic hepatitis following renal transplantation].

Sprengers D, van Gelder T, Zondervan PE, Niesters HG, Janssen HL, de Man RA. Sprengers D, et al. Among authors: janssen hl. Ned Tijdschr Geneeskd. 2002 Jul 20;146(29):1380-4. Ned Tijdschr Geneeskd. 2002. PMID: 12162178 Dutch.

5

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.

Buster EH, Hansen BE, Buti M, Delwaide J, Niederau C, Michielsen PP, Flisiak R, Zondervan PE, Schalm SW, Janssen HL; HBV 99-01 Study Group. Buster EH, et al. Among authors: janssen hl. Hepatology. 2007 Aug;46(2):388-94. doi: 10.1002/hep.21723. Hepatology. 2007. PMID: 17604363 Clinical Trial.

6

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Veldt BJ, et al. Among authors: janssen hl. Ann Intern Med. 2007 Nov 20;147(10):677-84. doi: 10.7326/0003-4819-147-10-200711200-00003. Ann Intern Med. 2007. PMID: 18025443

7

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.

Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Veldt BJ, et al. Among authors: janssen hl. Hepatology. 2008 Jun;47(6):1856-62. doi: 10.1002/hep.22251. Hepatology. 2008. PMID: 18506898

8

Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.

Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A. Claassen MA, et al. Among authors: janssen hl. J Hepatol. 2010 Mar;52(3):315-21. doi: 10.1016/j.jhep.2009.12.013. Epub 2009 Dec 24. J Hepatol. 2010. PMID: 20129690

9

[Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding].

Schouten JN, Verheij J, Janssen HL. Schouten JN, et al. Among authors: janssen hl. Ned Tijdschr Geneeskd. 2010;154:A1276. Ned Tijdschr Geneeskd. 2010. PMID: 20456763 Dutch.

10

Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?

Rijckborst V, Sonneveld MJ, Janssen HL. Rijckborst V, et al. Among authors: janssen hl. Aliment Pharmacol Ther. 2011 Mar;33(5):501-13. doi: 10.1111/j.1365-2036.2010.04555.x. Epub 2010 Dec 29. Aliment Pharmacol Ther. 2011. PMID: 21198707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

634 results

Search Page

Filters